HIGHLIGHTS
SUMMARY
In recent years, an increasing number of researchers have been using Raman spectroscopy (RS) technology to distinguish the biomarkers of healthy subjects from those of patients at different stages of CKD (Feng et_al, 2019; Chen et_al, 2020; Zong et_al, 2021). So far, progress has been made in monitoring the level of uric acid in blood and urine by using Raman spectroscopy (Alula et_al, 2019; Hernandez et_al, 2019; Wang et_al, 2019), and this approach has provided a simplified process for determining the uric acid content without the need for sample pretreatment. Hyperuricemia (HUA) is a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.